All India Institute Of Medical Sciences Tender

Work Description - Call For Objection For Procurement Of Injection Brolucizumab (pagenax) And Ranibizumab (accentrix) Of Make Novartis Pharma Ag For Aiims, Jammu On Proprietary Basis.

The All India Institute of Medical Sciences (AIIMS) Vijaypur, Jammu, a Central Government Ministry/Department, invites objections for the proposed procurement of Injection Brolucizumab (Pagenax) and Ranibizumab (Accentrix) manufactured by Novartis Pharma AG on a proprietary basis. This tender, referenced as AIIMS/JMU/PC/2025/08, is a single-stage procurement process for goods categorized as Consumables (Hospital / Lab). The estimated tender value is ₹1,08,24,128, with a work completion period of 60 days. Interested parties can download the tender documents starting March 21, 2025, at 10:15 AM, and submit their bids from March 21, 2025, at 10:30 AM until April 11, 2025, at 05:00 PM. The bid opening is scheduled for April 11, 2025, at 05:30 PM, at the 5th Floor, Procurement Section, Academic Block, AIIMS Vijaypur. The tender comprises two covers: a Fee/PreQual/Technical cover containing the objection for procurement of Anti-VEGF injections and a Finance cover for any financial objections. No EMD or Tender Fee is applicable for this tender. Submissions are to be addressed to the Deputy Director, Administration, AIIMS, Jammu, located at the 6th Floor Academic Block, AIIMS Vijaypur, Jammu and Kashmir, 181134.